Sinovac Covid-19 Vaccine | Page 3 | The Business Standard
Skip to main content
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
June 19, 2025

Sign In
Subscribe
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, JUNE 19, 2025

Sinovac Covid-19 Vaccine

A signage of Sinovac Biotech Ltd is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the Covid-19 outbreak, in Beijing, China September 5, 2020. Photo:Reuters
Coronavirus chronicle

Indonesia approves China's Sinovac vaccine, says 65.3% effective in trial

The authorisation came after interim data from a late-stage human trial in Indonesia showed the vaccine was 65.3% effective, Penny K. Lukito, who heads the country’s food and drugs regulator BPOM,...

Sinovac Covid-19 vaccine. Photo/TBS
Coronavirus chronicle

Brazil health regulator says application for Sinovac vaccine lacks information

A signage of Sinovac Biotech Ltd is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the Covid-19 outbreak, in Beijing, China September 5, 2020. Photo:Reuters
Coronavirus chronicle

Indonesian clerics declare Sinovac's Covid-19 vaccine halal

Shouldn’t this be available in America? Photographer: Nicolas Bock/Bloomberg
Covid-19 in Bangladesh

Chinese vaccine once offered to Dhaka now being used by other countries

A worker handles the Coronavac vaccines. Chinese vaccine developers have been at the forefront of the global race to create an effective immunization against the virus.  Photographer: Kevin Frayer/Getty Images
Coronavirus chronicle

Chinese CoronaVac remains promising in global vaccine race

A man works in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (Covid-19) vaccine, during a government-organized media tour in Beijing, China, 24 September, 2020/Reuters
Coronavirus chronicle

Piecemeal data releases threaten to undermine Sinovac's Covid-19 vaccine

A man works in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (Covid-19) vaccine, during a government-organized media tour in Beijing, China, 24 September, 2020/Reuters
Coronavirus chronicle

Sinovac secures $515 million funding to boost Covid-19 vaccine production

A man works in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (Covid-19) vaccine, during a government-organized media tour in Beijing, China, 24 September, 2020/Reuters
Coronavirus chronicle

Sinovac's Covid-19 vaccine induces quick immune response

Shouldn’t this be available in America? Photographer: Nicolas Bock/Bloomberg
Coronavirus chronicle

Brazil suspends Sinovac Covid-19 vaccine trial due to adverse event

Demonstrators carry a giant syringe as they protest against Sao Paulo state governor Joao Doria and China's Sinovac potential coronavirus disease (Covid-19) vaccine in Sao Paulo, Brazil, November 1, 2020/ Reuters
Coronavirus chronicle

Brazilians protest mandatory Covid-19 immunization, Chinese vaccine

A signage of Sinovac Biotech Ltd is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the Covid-19 outbreak, in Beijing, China September 5, 2020. Photo:Reuters
Covid-19 in Bangladesh

Bangladesh will not co-fund Sinovac's vaccine trial - Health Minister

A signage of Sinovac Biotech Ltd is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the Covid-19 outbreak, in Beijing, China September 5, 2020. Photo:Reuters
Coronavirus chronicle

China's Sinovac expects interim final-stage trial data on coronavirus vaccine this year

A signage of Sinovac Biotech Ltd is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the Covid-19 outbreak, in Beijing, China September 5, 2020. Photo:Reuters
Coronavirus chronicle

China's Sinovac coronavirus vaccine candidate appears safe, slightly weaker in elderly

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net